1 (Temozolomide Capsules 1)
Temozolomide Capsule
Product Images NDC 65162-802
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 65162-802). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
10 (Temozolomide Capsules 10)
This is a medicine called Temozolomide, in the form of capsules, manufactured by Amneal Pharmaceuticals LLC. The strength of each capsule is 140 mg and it is intended for oral administration. It is a cytotoxic medicine and should be taken as per the recommendations provided in the package insert. The capsules should not be opened and must be swallowed whole. The medicine should be stored in a controlled room temperature environment between 20°C and 25°C. The lot number, expiration date, and serialization details can be found in the designated area. The text is a mix of generated characters, symbols, and numbers.*
10 (Temozolomide Capsules 11)
This is a medication called Temozolomide USP, available in capsule form with a strength of 180 mg. The recommended dosage should be checked in the package insert, which also provides instructions for establishing a daily regimen. The capsules must be stored between 20°C to 25°C or 68°F to 77°F, with excursions permitted between 15°C to 30°C or 59°F to 86°F. The medication is intended for oral administration and must be stored in tight, light-resistant containers. The label includes the distributor's name, Amneal Pharmaceuticals LLC, along with their location in Bridgewater, NJ. The label also contains a product code and information about lot number and expiration date.*
10 (Temozolomide Capsules 12)
10 (Temozolomide Capsules 13)
This is a description of Temozolomide, a cytotoxic drug that comes in capsule form with a strength of 250mg per capsule. The dose should be determined by a healthcare provider and the package should be stored between 20°C to 25°C. The drug is supplied by Amneal Pharmaceuticals LLC in Bridgewater, NJ. The prescription should be dispensed in light-resistant containers. Lot number and exp. date information can be found in a non-varnish area of the packaging.*
10 (Temozolomide Capsules 14)
This is a description of Temozolomide Capsules, USP, which contain 250mg of temozolomide for oral administration. The package should be carefully reviewed for dosage recommendations and special dispensing instructions. The medication is cytotoxic and should not be opened, but swallowed whole, unless the capsule is damaged. The product should be stored at controlled room temperature. The manufacturer is Amneal Pharmaceuticals LLC, and the medication is distributed in a specific lot with an expiration date and serialization number.*
1 (Temozolomide Capsules 2)
The text appears to be sample statistical output showing survival data for a population based on overall survival with associated hazard ratios and P-values. It also includes a graph with months as the time variable. No additional information is available to provide further context.*
10 (Temozolomide Capsules 3)
This is a description of Temozolomide Capsules, USP used for oral administration. It contains 5mg of temozolomide, USP and is a cytotoxic medication that should be taken with caution by following the accompanying Rx only directions carefully. The package insert contains recommendations regarding the use of different capsule strengths to establish a daily regimen. It should be stored at a temperature of 20°C to 25°C and dispensed in tight, light-resistant containers as defined in the US Pharmacopeia. This medication is distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. Lot number and expiration date information is not available.*
10 (Temozolomide Capsules 4)
This is a medication information sheet for Temozolomide capsules. Each capsule contains 5mg of Temozolomide and is for oral administration. The capsules are cytotoxic and should not be opened but swallowed whole. The accompanying directions should be read carefully, and there are special dispensing instructions for pharmacists. The capsules should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (5°F to 86°F). Lot number, expiration date, and serialization information are provided on the unvarnished area on the sheet.*
10 (Temozolomide Capsules 5)
NDC number 65162-802-51 refers to Temozolomide capsules, USP containing 20mg of the medicine which is to be administered orally. These capsules are Cytotoxic and it is recommended to read accompanying directions carefully before use. Each capsule has 20mg of Temozolomide, USP. It is advisable to refer to the package insert for recommendations with respect to daily dosage based on varying capsule strengths. The capsules should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). Dispense the capsules in tight, light-resistant containers as defined in the USP. The medicine is distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. Lot no. and Exp. date not available.*
10 (Temozolomide Capsules 6)
This is a medication label for Temozolomide capsules used for oral administration. It advises not to open the capsules, swallow whole, and to avoid contact if the capsules are damaged. Pharmacists are asked to review the special dispensing information carefully. Storage instructions recommend a controlled room temperature of 20-25°C. Lot number and expiration date are included on the unvarnished area.*
10 (Temozolomide Capsules 7)
NDC 65162-803-51 is a product identifier for Temozolomide Capsules, USP which are given orally as a cytotoxic drug. The package inserts contain a recommendation for the use of varying capsule strengths in establishing a daily regimen, and it is important to carefully read the accompanying directions. Each capsule has 100mg of temozolomide, USP. Storage requirements are listed on the package, and it should be kept in a light-resistant container. The product is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. Lot number and expiration date information is present in a specific area of the packaging.*
10 (Temozolomide Capsules 8)
This is a description of Temozolomide capsules, a type of medication used for cancer treatment. The capsules are available in 100mg strength for oral administration. The recommended dosage should be determined by a physician. The capsules are cytotoxic and should not be opened, with damaged capsules avoided for contact with skin, eyes, or nose. Ideal storage conditions are between 20°C to 25°C. The medication is distributed by Amneal Pharmaceuticals LLC. The description also includes dispensing information and a product label, including lot number, expiration date, and serialization.*
10 (Temozolomide Capsules 9)
This text is a description of a medication with the NDC code 65162-804-51. Each capsule contains 140 mg of temozolomide, USP. It is advised to refer to the package insert for instructions on the use of varying capsule strengths to establish a daily regimen. Storage temperatures range from 20 to 25°C with excursions permitted between 15 to 30°C. Dispensing must be done in tight, light-resistant containers. This medication is for oral administration and is cytotoxic in nature. The text indicates the medication should be handled carefully by reading the accompanying directions. The medicine is distributed by Amneal Pharmaceuticals LLC based in Bridgewater, NJ. The lot number and expiry date are required to be mentioned in a non-varnish area.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
